Analytical Data
-
Gene name
Nkg7
- Application
-
Alternative Names
(Natural killer cell protein 7)
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q99PA5
-
Expression Region
1-165aa
-
Molecular Weight
19.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NKG7 (Natural Killer Group 7) is a protein that plays a critical role in the immune response, particularly in natural killer (NK) cells and cytotoxic T lymphocytes. As a member of the NKG family, NKG7 is involved in the regulation of granule exocytosis, which is essential for the elimination of infected or malignant cells. Research has indicated that NKG7 is not only pivotal for the activation of cytotoxic immune responses but also contributes to the development of immune memory. Its expression levels can be influenced by various factors, including cytokines and the immune status of an individual. The interest in NKG7-recombinant proteins has surged in recent years due to their potential therapeutic applications in cancer immunotherapy and infectious diseases. By engineering NKG7 as a recombinant protein, researchers aim to explore its functional roles further and assess its efficacy as a biomarker for immune status and as a target for enhancing NK cell activity. Understanding the biochemistry and functional dynamics of NKG7 could lead to novel strategies for modulating immune responses and improving outcomes in immunological disorders. The ongoing studies focus on characterizing the binding properties, signaling pathways, and overall contributions of NKG7 in immune regulation, which may provide insights into developing new immunotherapeutic approaches.
